Abstract DI-026 Table 1
Pomalidomide + low-dose dexamethasone
high-dose dexamethasone
OS benefit (months)
Difference in median survival method (months)
12.7
8.1
4.6
Area Under Curve method (months)
7.4
4.8
2.6